Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.04 -0.04 (-3.70%)
At close: Sep 9, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Market Capitalization (2016 - 2026)

Creative Medical Technology Holdings' (CELZ) quarterly Market Capitalization came in at $1.9 million in Q2 2026, down 45.28% year-over-year from $3.5 million in Q2 2025, and down 29.61% quarter-over-quarter from $2.7 million in Q1 2026.

Analysis

Creative Medical Technology Holdings (CELZ) Market Capitalization (2016 - 2026) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Market Capitalization for 11 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Market Capitalization fell 45.28% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $1.9 million, a 45.28% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 15.15% from the prior year.
  • Market Capitalization was $1.9 million for Q2 2026 at Creative Medical Technology Holdings, down from $2.7 million in the prior quarter.
  • Over five years, Market Capitalization peaked at $25.4 million in Q1 2022 and troughed at $1.9 million in Q2 2026.
  • A 5-year average of $5.9 million and a median of $4.8 million in 2024 frame the typical range for Market Capitalization.
  • Across the five-year window, Market Capitalization sank 83.35% in 2022 and surged 51.99% in 2023, its largest moves.
  • Over 5 years, Market Capitalization stood at $4.2 million in 2022, then surged by 51.99% to $6.3 million in 2023, then sank by 51.49% to $3.1 million in 2024, then declined by 15.15% to $2.6 million in 2025, then decreased by 26.02% to $1.9 million in 2026.
  • The last three Market Capitalization figures came in at $1.9 million (Q2 2026), $2.7 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Creative Medical Technology Holdings 1.45 Mn 1.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.93 Mn
Mar 31, 2026 2.74 Mn
Dec 31, 2025 2.61 Mn
Sep 30, 2025 4.43 Mn
Jun 30, 2025 3.52 Mn
Mar 31, 2025 2.89 Mn
Dec 31, 2024 3.07 Mn
Sep 30, 2024 4.12 Mn
Jun 30, 2024 5.15 Mn
Mar 31, 2024 7.06 Mn
Dec 31, 2023 6.33 Mn
Sep 30, 2023 6.84 Mn
Jun 30, 2023 6.63 Mn
Mar 31, 2023 7.04 Mn
Dec 31, 2022 4.17 Mn
Sep 30, 2022 6.19 Mn
Jun 30, 2022 6.76 Mn
Mar 31, 2022 25.43 Mn
Dec 31, 2021 5.76 Mn
Sep 30, 2021 18.39 Mn